Nurix Therapeutics Cash from Investing (TTM) Trends

Nurix Therapeutics Inc (NRIX)

13.44 -0.52 (-3.76%) USD | NASDAQ | May 10, 13:12

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
February 29, 2024	87.75M
November 30, 2023	68.30M
August 31, 2023	137.68M
May 31, 2023	51.83M
February 28, 2023	3.235M
November 30, 2022	27.20M
August 31, 2022	-64.33M

Date	Value
May 31, 2022	-13.49M
February 28, 2022	-65.83M
November 30, 2021	-108.25M
August 31, 2021	-196.29M
May 31, 2021	-292.14M
February 28, 2021	-237.37M
November 30, 2020	-254.40M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-292.14M

Minimum

May 2021

137.68M

Maximum

Aug 2023

-61.15M

Average

-38.91M

Median

Cash from Investing (TTM) Benchmarks